We are live on
!
Find out more
IG
Ithaka Group Portfolio holdings
AUM
$482M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+10.78%
1 Year Est. Return
+15.81%
3 Year Est. Return
+99.18%
5 Year Est. Return
+112.16%
10 Year Est. Return
+745.06%
AUM
$595M
AUM Growth
+$37.6M
(+6.7%)
Cap. Flow
-$7.31M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
55.65%
Holding
42
New
2
Increased
4
Reduced
26
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$27.5M |
| 2 |
XYZ
Block Inc
XYZ
|
+$10.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$5.12M |
| 4 |
ServiceNow
NOW
|
+$3.99M |
| 5 |
TransUnion
TRU
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$14.8M |
| 2 |
Edwards Lifesciences
EW
|
+$14.2M |
| 3 |
Palo Alto Networks
PANW
|
+$14.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 5 |
Booking.com
BKNG
|
+$5.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.92% |
| 2 | Financials | 21.68% |
| 3 | Consumer Discretionary | 19.51% |
| 4 | Healthcare | 12.38% |
| 5 | Communication Services | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$121B
| $8.95M | 1.5% |
54,923
-1,400
| -2% | -$229K |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.94M | 1.5% |
80,166
-1,182
| -1% | -$141K |
|
28
Incyte
INCY
$23.5B
| $6.94M | 1.17% |
83,269
-2,640
| -3% | -$238K |
|
|
29
BioMarin Pharmaceuticals
BMRN
$11.5B
| $4.83M | 0.81% |
59,641
+59,628
| +458,677% | +$5.12M |
|
30
Johnson Controls International
JCI
$87.5B
| $3.98M | 0.67% |
112,997
| – | – |
|
31
Adient
ADNT
$1.6B
| $1.05M | 0.18% |
17,549
| – | – |
|
32
Apple
AAPL
$4.89T
| $587K | 0.1% |
14,000
| – | – |
|
33
American Tower
AMT
$77.7B
| $465K | 0.08% |
3,200
| – | – |
|
34
Starbucks
SBUX
$118B
| $297K | 0.05% |
5,130
-427
| -8% | -$24.7K |
|
35
Procter & Gamble
PG
$343B
| $238K | 0.04% |
3,000
| – | – |
|
36
Equinix
EQIX
$107B
| $209K | 0.04% |
500
| – | – |
|
|
37
Palo Alto Networks
PANW
$264B
| $200K | 0.03% |
6,624
-508,008
| -99% | -$14.1M |
|
38
GE Aerospace
GE
$367B
| $155K | 0.03% |
2,400
| – | – |
|
|
39
Edwards Lifesciences
EW
$47.6B
| – | – |
-377,115
| Closed | -$14.2M |
|
40
iShares Russell 1000 Growth ETF
IWF
$122B
| – | – |
-18,400
| Closed | -$620K |
|
|
41
Regeneron Pharmaceuticals
REGN
$68.8B
| – | – |
-39,392
| Closed | -$14.8M |
|
Similar funds
SDWIA
BAG
EFA
MAM
NQWM
BAM
BWA
HC
Ithaka Group's Q1 2018 Portfolio in Review
As of Q1 2018, Ithaka Group held 42 positions worth $595M, up 6.7% from $558M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Ithaka Group's Q1 2018 filing shows 2 new, 4 increased, 26 reduced and 3 closed positions. Its largest new stake was Block Inc: 223,024 shares worth $11M. The largest sale was Regeneron Pharmaceuticals, an estimated $14.8M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Ithaka Group's largest Q1 2018 buy was Block Inc: 223,024 shares worth $11M.
- Ithaka Group added most to Microsoft in Q1 2018, an estimated $27.5M increase.
- Ithaka Group's biggest Q1 2018 reduction was Palo Alto Networks, cutting an estimated $14.1M.
- Ithaka Group fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $14.8M.
- Ithaka Group's ten largest holdings make up 56% of its $595M portfolio in Q1 2018.
- Ithaka Group opened 2 new positions and closed 3 in Q1 2018.
- Ithaka Group's portfolio value rose 6.7% quarter-over-quarter to $595M.
Based on Ithaka Group's 13F filing for Q1 2018, filed 14 May 2018.